1. Ziprasidone (CP-88,059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity;Seeger;J Pharmacol Exp Ther,1995
2. Ziprasidone—a new highly atypical antipsychotic;Chou;Essential Psychopharmacol,1998
3. Food and Drug Administration Center for Drug Evaluation Research. Transcript of FDA Psychopharmacological Drugs Advisory Committee hearing, July 19, 2000. Available at: http://www.fda.gov/ohrms/dockets/ac/cder00.htm#Psychopharmacologic%20Drugs. Accessed May 14, 2001.
4. Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers;Wilner;Br J Clin Pharmacol,2000